It is with great honor that we introduce Dr. Lynette Phillips as a Senior Pathologist at StageBio. We are happy to have her on the team and look forward to all she will accomplish!
As part of our pathologist team, Dr. Phillips will support StageBio’s mission by:
- Serving as subject matter expert and senior pathologist for safety and efficacy assessment of proof of concept and regulatory preclinical medical device studies.
- Dynamically foster productive collaborations with clients
“We are thrilled and proud that Dr. Lynette Phillips is joining the StageBio team. Her vast experience and expertise in preclinical medical devices constitute a strengthening of our team and consolidation of our leadership position in this area. We look forward to her contributions and all Lynette will accomplish for patients in need of safe therapeutics, for discerning clients and for the field of veterinary pathology!” – Serge Rousselle, Chief Scientific Officer
StageBio is committed to our mission of improving lives through high-quality histopathology, diagnostics and research. Join us in welcoming Lynette Phillips as part of this mission!
The Stagebio team is growing! If you are interested in learning more about our current open positions, please visit our careers page here.
About Lynette Phillips
Dr. Lynette Phillips brings over 20 years of experience in the field of veterinary anatomic pathology, the majority of which has focused on preclinical medical devices. Dr. Phillips received her D.V.M. from the University of Wisconsin-Madison and completed her residency in Anatomic Pathology at the University of Florida. Prior to joining StageBio, Dr. Phillips worked as a pathologist at medical device company Medtronic, Inc, and CRO American Preclinical Services, where she evaluated safety, biocompatibility and toxicologic studies in large and small animal models. Dr. Phillips originally completed her undergraduate and graduate training in chemical engineering, to which she attributes her interest in medical devices and implant pathology.
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates five GLP laboratories as well as three GLP specimen archiving facilities in the U.S., with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 60 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com.